Items where authors include "Baxter, M"
![[up]](/style/images/multi_up.png)
Up a levelArticle
dos Santos Lonsdale, M orcid.org/0000-0003-0315-6169, Baxter, M, Yao, Q et al. (2 more authors) (2024) Testing the effectiveness of a supportive digital information tool for patients recovering from bowel surgery, their surgeons and nurses. Information Design Journal, 28 (3). pp. 231-274. ISSN 1876-486X
Brown, JE, Royle, K-L orcid.org/0000-0003-0225-1199, Gregory, W et al. (96 more authors) (2023) Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. The Lancet Oncology, 24 (3). pp. 213-227. ISSN 1470-2045
Pearce, J, Swinson, D, Cairns, D orcid.org/0000-0002-2338-0179 et al. (7 more authors) (2022) Frailty and treatment outcome in advanced gastro-oesophageal cancer: An exploratory analysis of the GO2 trial. Journal of Geriatric Oncology, 13 (3). pp. 265-390. ISSN 1879-4068
Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736
Baxter, M, Lonsdale, MDS orcid.org/0000-0003-0315-6169 and Westland, S orcid.org/0000-0003-3480-4755 (2021) Utilising design principles to improve the perception and effectiveness of public health infographics. Information Design Journal. ISSN 1876-486X
Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736
Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736
Yang, N, Berry, A, Sauer, C et al. (6 more authors) (2020) Hypoxia regulates GR function through multiple mechanisms involving microRNAs 103 and 107. Molecular and Cellular Endocrinology, 518. 111007. ISSN 0303-7207
Kitchen, GB, Cunningham, PS, Poolman, TM et al. (14 more authors) (2020) The clock gene Bmal1 inhibits macrophage motility, phagocytosis, and impairs defense against pneumonia. Proceedings of the National Academy of Sciences of USA, 117 (3). pp. 1543-1551. ISSN 0027-8424
Baxter, M, Voronkov, M, Poolman, T et al. (19 more authors) (2020) Cardiac mitochondrial function depends on BUD23 mediated ribosome programming. eLife, 9. e50705. ISSN 2050-084X
Lonsdale, MDS orcid.org/0000-0003-0315-6169, David, L, Baxter, M et al. (4 more authors) (2019) Visualizing the terror threat. Visible Language, 53 (2). pp. 37-71. ISSN 0022-2224
Johal, S, Nakano, N, Baxter, M et al. (3 more authors) (2018) Unicompartmental Knee Arthroplasty: The Past, Current Controversies, and Future Perspectives. The Journal of Knee Surgery, 31 (10). pp. 992-998. ISSN 1538-8506
Caratti, G, Iqbal, M, Hunter, L et al. (23 more authors) (2018) REVERBa couples the circadian clock to hepatic glucocorticoid action. The Journal of Clinical investigation, 128 (10). pp. 4454-4471. ISSN 0021-9738
Caratti, G, Matthews, L, Poolman, T et al. (3 more authors) (2015) Glucocorticoid receptor function in health and disease. Clinical Endocrinology, 83 (4). pp. 441-448. ISSN 0300-0664
Monograph
Newbronner, L, Baxter, M, Chamberlain, R et al. (3 more authors) (2007) Research into the Longer Term Effects/Impacts of Re-ablement Services. Research Report. Homecare Re-ablement Workstream, Care Services Efficiency Delivery Programme , London.